Iatrogenic cerebral amyloid angiopathy linked to high recurrent hemorrhage risk
A multinational case series of 82 patients with iatrogenic cerebral amyloid angiopathy (iCAA) found a symptomatic intracerebral hemorrhage (ICH) rate of 19.2 per 100 patient-years after first presentation, the study reports. Patients who initially presented with ICH had a higher recurrence rate (24.6 per 100 patient-years) than those with other presentations, and those exposed via spinal surgery had a lower ICH rate than those exposed via brain surgery or embolization, according to the authors. Despite frequent hemorrhage, mortality was low (7.3%), while cognitive impairment was recorded in just over half of patients at last follow-up.
Most relevant for: Patients diagnosed with iatrogenic cerebral amyloid angiopathy following prior neurosurgical or embolization procedures.
Read the original at NeurologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More neurology updates
- Intensive BP Lowering Benefits Deep but Not Lobar HemorrhageNov 10, 2026
- Earlier Blood Biomarker Disclosure Boosts Diagnostic Certainty in Memory ClinicOct 5, 2026
- Study identifies clinical risk factors for chemotherapy-induced nerve toxicityOct 27, 2026
- Cervical cord atrophy in MS exceeds normal age-related declineOct 27, 2026
- RIPK1 Inhibitor SAR443820 Fails to Slow ALS Progression in Phase 2 TrialOct 1, 2026